-+ 0.00%
-+ 0.00%
-+ 0.00%

Kala Bio preliminary Q3 2026 net loss narrows about 90% year over year to $800,000

PUBT·11/09/2026 13:05:59
Listen to the news
Kala Bio preliminary Q3 2026 net loss narrows about 90% year over year to $800,000
  • Kala Bio’s preliminary third-quarter 2026 net loss narrowed approximately 90% year over year to about $800,000.
  • Net loss for the nine months ended September 30, 2026, narrowed 86% year over year to approximately $4 million.
  • Cash, cash equivalents and short-term investments totaled approximately $7 million at September 30, 2026, with no debt.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611090800NEWSFILECNPR____20261109_323085_1) on November 09, 2026, and is solely responsible for the information contained therein.